Parallel Advisors, LLC Esperion Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

$4.18 Billion
Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 244,000 shares of ESPR stock, worth $588,040. This represents 0.01% of its overall portfolio holdings.

Number of Shares

244,000

Previous 239,000 2.09%

Holding current value

$588,040

Previous $530,000 24.15%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.61 - $2.73 $8,050 - $13,650	5,000 Added 2.09%	244,000 $402,000
Q1 2024 May 06, 2024	SELL	$2.02 - $3.02 $482,780 - $721,780	-239,000 Reduced 50.0%	239,000 $640,000
Q3 2023 May 20, 2024	BUY	$0.96 - $1.79 $458,717 - $855,317	477,831 Added 282740.25%	478,000 $468,000
Q3 2023 Nov 13, 2023	BUY	$0.96 - $1.79 $458,880 - $855,620	478,000 New	478,000 $468,000
Q1 2023 May 20, 2024	SELL	$1.46 - $7.3 $348,693 - $1.74 Million	-238,831 Reduced 99.93%	169 $0
Q1 2023 Apr 25, 2023	BUY	$1.46 - $7.3 $246 - $1,233	169 New	169 $0
Q3 2022 Nov 10, 2022	BUY	$5.45 - $8.13 $98 - $146	18 Added 51.43%	53 $0
Q2 2022 Aug 01, 2022	BUY	$4.77 - $6.67 $166 - $233	35 New	35 $0
Q1 2022 Apr 28, 2022	SELL	$3.34 - $5.56 $5,096 - $8,484	-1,526 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$4.81 - $11.92 $6,733 - $16,688	1,400 Added 1111.11%	1,526 $8,000
Q3 2021 Nov 02, 2021	BUY	$11.34 - $21.37 $1,406 - $2,649	124 Added 6200.0%	126 $2,000
Q1 2021 Apr 23, 2021	SELL	$25.12 - $36.89 $75 - $110	-3 Reduced 60.0%	2 $0
Q4 2020 Feb 02, 2021	SELL	$24.2 - $35.76 $121 - $178	-5 Reduced 50.0%	5 $0
Q3 2020 Oct 27, 2020	BUY	$31.18 - $52.71 $311 - $527	10 New	10 $0
Q2 2020 Jul 16, 2020	SELL	$30.04 - $51.31 $532,008 - $908,700	-17,710 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$35.4 - $59.82 $354,000 - $598,200	10,000 Added 129.7%	17,710 $1.06 Million
Q3 2019 Nov 01, 2019	BUY	$34.47 - $47.53 $265,763 - $366,456	7,710 New	7,710 $283,000
Q2 2019 Aug 05, 2019	SELL	$40.1 - $52.33 $80,200 - $104,660	-2,000 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$40.11 - $53.57 $80,220 - $107,140	2,000 New	2,000 $80,000

Others Institutions Holding ESPR

# of Institutions

208

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Esperion Therapeutics, Inc. Transaction History